Real-world data of cardiotoxicity during long-term therapy with trastuzumab in human epidermal growth factor receptor-2-positive metastatic breast cancer

Introduction/Objective. This study aims to investigate the cardiotoxicity of long-term therapy with trastuzumab in patients with HER-2-positive metastatic breast cancer. Methods. A total of 48 patients with metastatic HER-2-positive breast cancer were analyzed. The patients received long-term trastu...

Cijeli opis

Bibliografski detalji

Glavni autori:	Iljovska Marina, Lazareva Emilija, Smichkoska Snezhana, Klisarovska Violeta, Stojkovski Igor, Petkovska Gordana, Mitreski Nenad
Format:	Artigo
Jezik:	Inglês
Izdano:	Serbian Medical Society 2023-01-01
Serija:	Srpski Arhiv za Celokupno Lekarstvo
Teme:	breast cancer cardiotoxicity ejection fraction safety trastuzumab
Online pristup:	http://www.doiserbia.nb.rs/img/doi/0370-8179/2023/0370-81792200113I.pdf
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!